NumerixS Investment Technologies’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-7,300
Closed -$142K 1465
2018
Q1
$142K Buy
7,300
+5,561
+320% +$109K 0.04% 538
2017
Q4
$29K Sell
1,739
-19,361
-92% -$355K 0.01% 955
2017
Q3
$428K Buy
+21,100
New +$403K 0.09% 271
2017
Q1
Sell
-18,700
Closed -$248K 1487
2016
Q4
$248K Sell
18,700
-16,500
-47% -$282K 0.03% 607
2016
Q3
$834K Buy
35,200
+5,183
+17% +$139K 0.11% 237
2016
Q2
$865K Buy
30,017
+18,247
+155% +$595K 0.12% 241
2016
Q1
$377K Buy
+11,770
New +$414K 0.04% 572

NumerixS Investment Technologies's IPXL Position: Q2 2018 in Review

NumerixS Investment Technologies sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 7,300 shares — an estimated $142K sold.

NumerixS Investment Technologies first reported a position in IPXL in Q1 2016 and held it in 7 quarters. The position peaked at $865K in Q2 2016. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • NumerixS Investment Technologies reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • NumerixS Investment Technologies sold 7,300 Impax Laboratories, Inc. shares in Q2 2018, an estimated $142K.
  • NumerixS Investment Technologies first reported a position in Impax Laboratories, Inc. in Q1 2016 and held it in 7 quarters.
  • NumerixS Investment Technologies's Impax Laboratories, Inc. position peaked at $865K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on NumerixS Investment Technologies's 13F filing for Q2 2018, filed 10 Aug 2018.